Skip to content
DataLookout
Menu

NCT07021742

BioHealx® Anal Fistula Device Post Market Surveillance Study

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 24 words
    • Primary completion pushed from Oct 2026 to Feb 2027
    • Study completion pushed from Dec 2026 to Mar 2027
    • Secondary endpoints: details revised at 5 of 5 entries
  2. Minor Study sites: 5 to 6v5
  3. Minor Study sites: 2 to 5v4
  4. Minor Study sites: 1 to 2v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2025 to Jun 14, 2025
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Successful Closure Repair
Timeframe: 12 Months
Non-Recurrence Incidence
Timeframe: 24 and 36 Months

Secondary (5)

Fecal Incontinence Quality of Life
Fecal Incontinence Severity Index (FISI)
Health Related Quality of Life
Pain Score
Rescue Analgesic and Therapeutic Antibiotic Use

Arms and interventions

BioHealx

Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device.

Devices: BioHealx

Sites

6 sites in 1 country